Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Asker Healthcare Group ABOSTO:ASKER +0.76%11 Equity-to-Asset is 0.39 as of Jun. 2026, which is at its 10-year median of 0.39. GuruFocus rates OSTO:ASKER with a GF Score™ of 11/100. The stock has 3 warning signs investors should review. Among 123 Medical Distribution companies, Asker Healthcare Group AB ranks worse than 51.22% on this metric.
The historical rank and industry rank for Asker Healthcare Group AB's Equity-to-Asset or its related term are showing as below:
OSTO:ASKER'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.26 Med: 0.39 Max: 0.44
Current: 0.39
During the past 4 years, the highest Equity to Asset Ratio of Asker Healthcare Group AB was 0.44. The lowest was 0.26. And the median was 0.39.
OSTO:ASKER's Equity-to-Asset is ranked worse than 51.22% of 123
companies
in the Medical Distribution industry
Industry Median: 0.4
vs OSTO:ASKER: 0.39
Asker Healthcare Group AB (OSTO:ASKER) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Asker Healthcare Group AB Equity-to-Asset Related Terms
Asker Healthcare Group AB Equity-to-Asset Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:ASKER vs MCK, COR, CAH: Equity-to-Asset Comparison
For the Medical Distribution subindustry, Asker Healthcare Group AB's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Asker Healthcare Group AB Equity-to-Asset vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Asker Healthcare Group AB's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Asker Healthcare Group AB's Equity-to-Asset falls into.
Asker Healthcare Group AB Equity-to-Asset Calculation
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Asker Healthcare Group AB's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Asker Healthcare Group AB (OSTO:ASKER) has a Equity-to-Asset of 0.39 as of Jun. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Asker Healthcare Group AB and its competitors. This is near median its historical median of 0.39. Over the past decade, Asker Healthcare Group AB's Equity-to-Asset has ranged from 0.26 to 0.44. According to the industry distribution chart, Asker Healthcare Group AB ranks #63 out of 123 companies in the Medical Distribution industry, placing it in the top 51.2%.
Is Asker Healthcare Group AB's Equity-to-Asset too high?
Asker Healthcare Group AB's current Equity-to-Asset of 0.39 is near median its 10-year median of 0.39. Over the past 10 years, this metric has ranged from a low of 0.26 to a high of 0.44. The Medical Distribution industry median Equity-to-Asset is 0.40. Asker Healthcare Group AB's value of 0.39 is 2.5% below this industry median. Based on the distribution chart, Asker Healthcare Group AB ranks #63 out of 123 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Asker Healthcare Group AB has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Asker Healthcare Group AB's Equity-to-Asset compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Asker Healthcare Group AB ranks #63 out of 123 companies for Equity-to-Asset. This places Asker Healthcare Group AB in the lower half of its industry. The industry median Equity-to-Asset is 0.40. Asker Healthcare Group AB's value of 0.39 is 2.5% below this benchmark. Historically, Asker Healthcare Group AB's own Equity-to-Asset has ranged from 0.26 to 0.44 over the past decade. While the company's 10-year median is 0.39 vs. the industry median of 0.40, Asker Healthcare Group AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Medical Distribution company?
The median Equity-to-Asset among Medical Distribution companies is 0.40, based on 123 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Asker Healthcare Group AB's current Equity-to-Asset of 0.39 is 2.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Asker Healthcare Group AB and its competitors. For the Medical Distribution industry, the median Equity-to-Asset is 0.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Asker Healthcare Group AB's current Equity-to-Asset is 0.39, which is near median its own 10-year median of 0.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Asker Healthcare Group AB stock overvalued right now?
Asker Healthcare Group AB (OSTO:ASKER) has a current Equity-to-Asset of 0.39. The current Equity-to-Asset is 0.39, which is near median its 10-year median of 0.39 and 2.5% below the Medical Distribution industry median of 0.40. Asker Healthcare Group AB's overall GF Score™ is 11/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Asker Healthcare Group AB (OSTO:ASKER), the current Equity-to-Asset is 0.39 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Asker Healthcare Group AB is a provider of medical products and solutions that drive progress in the European healthcare sector. The company is engaged in building and acquiring companies to support the healthcare system to improve patient outcomes, reduce the total cost of care, and ensure a fair and sustainable value chain. The company also offers a range of value-added solutions to support its suppliers and customers in, for example, market access, efficiency, and sustainability. Company has adapted a twin engine growth strategy that combines organic and acquired growth. Geographically, the company evaluates the operations in three business areas: North, West and Central.
11GF Score
Get the complete analysis for OSTO:ASKER
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:ASKER has been successfully added to your 
